Posts in category Business Standard
FMCG shares gain (24-06-2024)
FMCG stocks were trading in the positive zone, with the BSE Fast Moving Consumer Goods index rising 92.99 points or 0.46% at 20418.87 at 09:47 IST.
Consumer Durables shares rise (24-06-2024)
Consumer Durables stocks were trading with gains, with the BSE Consumer Durables index rising 93.64 points or 0.16% at 58862.4 at 09:47 IST.
Capital Goods shares gain (24-06-2024)
Capital Goods stocks were trading in the positive zone, with the BSE Capital Goods index rising 94.78 points or 0.13% at 71874 at 09:47 IST.
RVNL stock hits fresh 52-week high on securing order worth of Rs 192 cr (24-06-2024)
The uptick in share price came after the RVNL announced that it has emerged as the lowest bidder (L-1) for a project worth Rs 192 crore from South Eastern Railway
Market drifts lower; Sensex slides 270 pts; breadth negative (24-06-2024)
At 09:30 IST, the barometer index, the S&P BSE Sensex, was down 270.14 points or 0.35% to 76,939.76. The Nifty 50 index lost 91.80 points or 0.39% to 23,399.90.
Semiconductor firm MosChip stock up 150% in June; will the rally continue? (24-06-2024)
MosChip hit a new all-time high at Rs 320.80 on Friday June 21. The stock may witness some consolidation in the near-term, post which a rally to Rs 395 levels seems possible, chart shows.
Infibeam Avenues collaborates with EDII, Ahmedabad (24-06-2024)
To foster AI adoption in India
Best Crop Science receives license to manufacture herbicide – Haloxyfop-R-methyl ester (24-06-2024)
Best Crop Science, a wholly owned subsidiary of Best Agrolife, has been granted Licence for indigenous manufacture of Haloxyfop R-methyl ester Technical 96% w/w min u/s 9(3) by Central Insecticides Board & Registration Committee.
Bet on these stocks to mint money on your friend’s big fat Indian wedding (24-06-2024)
An average Indian couple spends around 2x on weddings versus education (pre-primary to graduation), according to the Jefferies note, which is in sharp contrast to countries such as the United States
Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units (24-06-2024)
Biocon Biologics, a subsidiary of Biocon, has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new, world-class, multi-product monoclonal antibodies (mAbs) drug substance facility at Bengaluru.